Stock listing
Artelo Biosciences, Inc.
Selected listing: ARTL · BOATS · USD · US
Artelo Biosciences, Inc. (BOATS:ARTL), Health Technology. Latest release Sep 23, 2026: Artelo Biosciences Files New Provisional Patent Application Covering…
- Ticker
- BOATS:ARTL
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- BOATS
- Currency
- USD
About Artelo Biosciences, Inc.
Artelo Biosciences, Inc. is a public company traded under the ticker ARTL in the American market. Artelo focuses on developing innovative therapies, particularly in the field of cannabinoid-based treatments.
Latest news from Artelo Biosciences, Inc.
Artelo Biosciences Files New Provisional Patent Application Covering ART27.13 for Obesity, Alone and in Combination with GLP-1 Receptor Agonists, Following Unexpected Nonclinical Findings
September 23, 2026
Artelo Biosciences Announces ART27.13 Achieved Weight Loss Comparable to Semaglutide as a Monotherapy and Doubled Weight Loss in Combination with Semaglutide in a Nonclinical Model of Obesity
September 16, 2026
Artelo Biosciences to Present at the H.C. Wainwright 28th Annual Global Investment Conference
September 8, 2026
Artelo Biosciences Receives a Notice of Allowance from the U.S. Patent and Trademark Office for its Lead Investigational Drug Currently in Two Phase 2 Studies
August 17, 2026
Artelo Biosciences Provides Business Update and Reports 2026 Second Quarter Financial Results
August 13, 2026
Research Artelo Biosciences, Inc.
Artelo Biosciences, Inc. company profile
View the public company page for Artelo Biosciences, Inc. on 6ix.
Artelo Biosciences, Inc. news
Read company news and market updates connected to Artelo Biosciences, Inc..
Artelo Biosciences, Inc. investor events
Find investor webinars, events, and replay context for Artelo Biosciences, Inc..